Observational Study Protocol: LIVER-R
Conditions: Hepatobiliary Cancers Interventions: Other: Durvalumab-based combination therapies in observational study setting; Other: Durvalumab-based combination therapies in observational study setting Sponsors: AstraZeneca; ICON plc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Cancer | Cancer & Oncology | Liver | Research | Study | Urology & Nephrology